• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.10% Nasdaq Down0.20%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    4.99 Down 0.01(0.20%) 1:07PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 5,095   1,396   1,937   248  
    Cost of Revenue(321)159  178  (16)
    Gross Profit 5,416   1,237   1,759   264  
    Operating Expenses
    Research Development8,605  6,766  6,362  6,463  
    Selling General and Administrative4,858  4,235  6,798  3,893  
    Non Recurring(343)123  178  42  
    Others(398)137  129  132  
    Total Operating Expenses12,722  11,261  13,467  10,530  
    Operating Income or Loss (7,306) (10,024) (11,708) (10,266)
    Income from Continuing Operations
    Total Other Income/Expenses Net19  10  11  12  
    Earnings Before Interest And Taxes(7,287)(10,014)(11,697)(10,254)
    Interest Expense -   -   -   -  
    Income Before Tax(7,287)(10,014)(11,697)(10,254)
    Income Tax Expense(133) -   -   -  
    Minority Interest7   -   -   -  
    Net Income From Continuing Ops(7,147)(10,014)(11,697)(10,254)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,147) (10,014) (11,697) (10,254)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,147) (10,014) (11,697) (10,254)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.